Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3798-3803, September 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, T. K.
Right arrow Articles by Yandell, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, T. K.
Right arrow Articles by Yandell, D.

Genomic DNA-based hMSH2 and hMLH1 Mutation Screening in 32 Eastern United States Hereditary Nonpolyposis Colorectal Cancer Pedigrees1

Thomas K. Weber2, Wendy Conlon, Nicholas J. Petrelli, Miguel Rodriguez-Bigas, Bernadette Keitz, James Pazik, Carolyn Farrell, Linda O'Malley, Maximillian Oshalim, May Abdo, Garth Anderson, Daniel Stoler and David Yandell

Departments of Surgery [T. K. W., N. J. P., M. R-B., B. K., J. P., C. F., L. O., M. O., M. A.] and Cell and Molecular Biology [G. A., D. S.], Roswell Park Cancer Institute, Buffalo, New York 14263, and Vermont Cancer Center and Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont 05410 [W. C., D. Y.]

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant cancer syndrome characterized by early age of onset colorectal cancer (mean 45 years) as well as endometrial, urinary tract, and upper gastrointestinal adenocarcinomas. The HNPCC phenotype has been shown to segregate with germline mutations in the human homologues of the DNA mismatch repair genes MSH2, MLH1, PMS1, and PMS2. However, the majority of published DNA mismatch repair gene mutation surveys associated with HNPCC kindreds report multiple levels of prese-lection, including 2p and 3p chromosomal linkage analysis and the evaluation of microsatellite instability of proband colorectal cancers prior to mutation analysis. For this reason, the concise contribution of each of the known DNA mismatch repair genes to the HNPCC phenotype remains unknown. We report the results of a genomic DNA-based analysis of hMSH2 and hMLH1 germline mutations in 32 unrelated Eastern United States HNPCC kindreds. These families were selected for study on the basis of phenotype only. We identified three hMSH2 and six hMLH1 mutations in eight families, for a positive mutation rate of 25%. Two mutations were identified in one of the families. Four of the mutations detected have not been reported in the literature previously. One of the mutation-positive families is African American; the others were of European-American ancestry. These results provide a clarification of the contribution of hMSH2 and hMLH1 to the HNPCC phenotype and suggest that in the majority of Eastern United States HNPCC kindreds selected by phenotype alone, the molecular genetic basis for the disease remains unknown.

1 This work was supported by a grant from the Research Foundation of the American Society of Colorectal Surgeons and National Cancer Institute Cancer Center Support Grant P30 CA-16056. T. K. W. is an American Cancer Society Career Development Awardee.

2 To whom requests for reprints should be addressed, at Department of Surgery, Roswell Park Cancer Institute, Elm & Carlton Streets. Buffalo, NY 14263.

Received 4/23/97. Accepted 7/ 7/97.




This article has been cited by other articles:


Home page
JCOHome page
T. Goecke, K. Schulmann, C. Engel, E. Holinski-Feder, C. Pagenstecher, H. K. Schackert, M. Kloor, E. Kunstmann, H. Vogelsang, G. Keller, et al.
Genotype-Phenotype Comparison of German MLH1 and MSH2 Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC Consortium
J. Clin. Oncol., September 10, 2006; 24(26): 4285 - 4292.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. O. Woods, A. J. Hyde, F. K. Curtis, S. Stuckless, J. S. Green, A. F. Pollett, J. D. Robb, R. C. Green, M. E. Croitoru, A. Careen, et al.
High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes
Clin. Cancer Res., October 1, 2005; 11(19): 6853 - 6861.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Oda, Y. Maehara, Y. Ikeda, E. Oki, A. Egashira, Y. Okamura, I. Takahashi, Y. Kakeji, Y. Sumiyoshi, K. Miyashita, et al.
Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability
Nucleic Acids Res., March 18, 2005; 33(5): 1628 - 1636.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Listgarten, S. Damaraju, B. Poulin, L. Cook, J. Dufour, A. Driga, J. Mackey, D. Wishart, R. Greiner, and B. Zanke
Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms
Clin. Cancer Res., April 15, 2004; 10(8): 2725 - 2737.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Renkonen, Y. Zhang, H. Lohi, R. Salovaara, W. M. Abdel-Rahman, M. Nilbert, K. Aittomaki, H. J. Jarvinen, J.-P. Mecklin, A. Lindblom, et al.
Altered Expression of MLH1, MSH2, and MSH6 in Predisposition to Hereditary Nonpolyposis Colorectal Cancer
J. Clin. Oncol., October 1, 2003; 21(19): 3629 - 3637.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M Palicio, J Balmana, S Gonzalez, I Blanco, E Marcuello, M A Peinado, G Julia, J R Germa, J J Lopez Lopez, J Brunet, et al.
Mismatch repair gene analysis in Catalonian families with colorectal cancer
J. Med. Genet., June 1, 2002; 39(6): e29 - 29.
[Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yamamoto, F. Itoh, H. Nakamura, H. Fukushima, S. Sasaki, M. Perucho, and K. Imai
Genetic and Clinical Features of Human Pancreatic Ductal Adenocarcinomas with Widespread Microsatellite Instability
Cancer Res., April 1, 2001; 61(7): 3139 - 3144.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. C. Curia, R. Palmirotta, G. Aceto, L. Messerini, M. C. Veri, S. Crognale, R. Valanzano, F. Ficari, P. Fracasso, V. Stigliano, et al.
Unbalanced Germ-Line Expression of hMLH1 and hMSH2 Alleles in Hereditary Nonpolyposis Colorectal Cancer
Cancer Res., August 1, 1999; 59(15): 3570 - 3575.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Syngal, E. A. Fox, C. Li, M. Dovidio, C. Eng, R. D. Kolodner, and J. E. Garber
Interpretation of Genetic Test Results for Hereditary Nonpolyposis Colorectal Cancer: Implications for Clinical Predisposition Testing
JAMA, July 21, 1999; 282(3): 247 - 253.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M P. de Leon, M Pedroni, P Benatti, A Percesepe, C Di Gregorio, M Foroni, G Rossi, M Genuardi, G Neri, F Leonardi, et al.
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis
Gut, July 1, 1999; 45(1): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. K. Weber, H.-M. Chin, M. Rodriguez-Bigas, B. Keitz, R. Gilligan, L. O'Malley, E. Urf, N. Diba, J. Pazik, and N. J. Petrelli
Novel hMLH1 and hMSH2 Germline Mutations in African Americans With Colorectal Cancer
JAMA, June 23, 1999; 281(24): 2316 - 2320.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
H. T. Lynch, M. J. Casey, T. G. Shaw, and J. F. Lynch
Hereditary Factors in Gynecologic Cancer
Oncologist, October 1, 1998; 3(5): 319 - 338.
[Abstract] [Full Text]


Home page
NEJMHome page
J. T. Wijnen, H. F.A. Vasen, P. M. Khan, A. H. Zwinderman, H. van der Klift, A. Mulder, C. Tops, P. Moller, R. Fodde, F. Menko, et al.
Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer
N. Engl. J. Med., August 20, 1998; 339(8): 511 - 518.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. De las Alas, R. A. M. de bruin, L. T. Eyck, G. Los, and S. B. Howell
Prediction-based threading of the hMSH2 DNA mismatch repair protein
FASEB J, June 1, 1998; 12(9): 653 - 663.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.